NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 59 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q1 2014. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $139,000 | -6.1% | 255,495 | +0.1% | 0.00% | – |
| Q2 2016 | $148,000 | -66.4% | 255,219 | -15.5% | 0.00% | – |
| Q1 2016 | $441,000 | -53.8% | 302,182 | +1.3% | 0.00% | -100.0% |
| Q4 2015 | $954,000 | -48.7% | 298,336 | +0.2% | 0.00% | 0.0% |
| Q3 2015 | $1,860,000 | -39.1% | 297,803 | -3.2% | 0.00% | -50.0% |
| Q2 2015 | $3,056,000 | +74.5% | 307,783 | +29.5% | 0.00% | +100.0% |
| Q1 2015 | $1,751,000 | +44.4% | 237,609 | +4.8% | 0.00% | 0.0% |
| Q4 2014 | $1,213,000 | +8.6% | 226,831 | +2.1% | 0.00% | 0.0% |
| Q3 2014 | $1,117,000 | -24.3% | 222,214 | +1.0% | 0.00% | 0.0% |
| Q2 2014 | $1,476,000 | +29.4% | 220,093 | +39.5% | 0.00% | 0.0% |
| Q1 2014 | $1,141,000 | +215.2% | 157,725 | +64.0% | 0.00% | – |
| Q4 2013 | $362,000 | +70.8% | 96,193 | +51.8% | 0.00% | – |
| Q3 2013 | $212,000 | – | 63,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 25,915,937 | $14,062,000 | 0.57% |
| Family Management Corp | 105,975 | $58,000 | 0.03% |
| HYMAN CHARLES D | 249,625 | $135,000 | 0.02% |
| Montecito Bank & Trust | 75,717 | $41,000 | 0.02% |
| WEDBUSH SECURITIES INC | 162,200 | $88,000 | 0.01% |
| Cutler Group LLC / CA | 9,600 | $105,000 | 0.01% |
| WHALEROCK POINT PARTNERS, LLC | 15,000 | $8,000 | 0.00% |
| TELEMUS CAPITAL, LLC | 32,401 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 15,504 | $8,000 | 0.00% |
| Creative Planning | 413,500 | $224,000 | 0.00% |